Wells Fargo Raises its Price Target on The Clorox Company (CLX) to $125 and Maintains an Equal Weight Rating

Core Insights - The Clorox Company (NYSE:CLX) is recognized as one of the 11 Best High Growth Consumer Stocks to Buy currently [1] - Analysts have raised price targets for Clorox, reflecting positive sentiment in the consumer staples sector [2][3] Financial Performance - Clorox reported Q2 revenue of $1.67 billion, exceeding consensus estimates of $1.64 billion [4] - The company’s Chair and CEO, Linda Rendle, indicated that results align with expectations and support the fiscal year outlook despite a challenging environment [4] Analyst Ratings and Price Targets - Wells Fargo analyst Chris Carey increased the price target for Clorox to $125 from $115, maintaining an Equal Weight rating [2] - Rothschild & Co Redburn raised its price target to $117 from $115 while keeping a Neutral rating, noting a 14% gain in the home and personal care sector in 2026 [3] - BofA analyst Anna Lizzul raised the price target to $112 from $110 but maintained a Neutral rating, citing gross margin pressure and uncertainty in consumption and margins for the second half [3] Strategic Focus - Clorox is focused on executing second-half plans and advancing its transformation, including the acquisition of GOJO Industries to enhance its leadership in health and hygiene [4]